Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The evolutionarily conserved Tre2/Bub2/Cdc16 (TBC), Lysin motif (LysM), Domain catalytic (TLDc) domain is neuroprotective against oxidative stress.
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
White and gray matter damage in primary progressive MS: The chicken or the egg?
Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers.
The triggering receptor expressed on myeloid cells 2 - a molecular link of neuroinflammation and neurodegenerative diseases.
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.
Monoclonal antibodies as disease modifying therapy in multiple sclerosis.
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
Venous endothelial injury in central nervous system diseases.
Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study.
The MoSt Project--More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.
Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study.
Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.
Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.
Multiple sclerosis: Drug-enhanced remyelination in a multiple sclerosis model.
Pathophysiology, assessment and management of multiple sclerosis spasticity: an update.
Support our campaign for better treatment for people with MS.
The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis.
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Pharmaceutical approval update.
CXCL10 Triggers Early Microglial Activation in the Cuprizone Model.
Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.
Regenerative Medicines for Remyelination: From Aspiration to Reality.
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study.
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.

Pages